Implications of continued response after autologous stem cell transplantation for multiple myeloma

Patients undergoing autologous stem cell transplantation (ASCT) for multiple myeloma (MM) undergo disease assessment approximately 100 days later. Some patients continue to have a decline in their serum or urine monoclonal protein after day 100 in the absence of additional therapy. We evaluated 430...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Gonsalves, Wilson I., Gertz, Morie A., Dispenzieri, Angela, Lacy, Martha Q., Lin, Yi, Singh, Preet P., Gupta, Vinay, Hayman, Suzanne R., Buadi, Francis K., Dingli, David, Kapoor, Prashant, McCurdy, Arleigh R., Kumar, Shaji K.
Format: Artigo
Idioma:Inglês
Publicat: American Society of Hematology 2013
Matèries:
Lymphoid Neoplasia
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3765057/
https://ncbi.nlm.nih.gov/pubmed/23863899
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2013-03-492678
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars